Skip to content

A randomized controlled clinical trial on the efficacy and safety of acupuncture in the treatment of essential hypertension

A randomized controlled clinical trial on the efficacy and safety of acupuncture in the treatment of essential hypertension

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002379
Enrollment
Unknown
Registered
2025-12-06
Start date
2025-07-28
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential hypertension

Interventions

Control group:Original antihypertensive treatment regimen

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria Only patients who meet all of the following five criteria can be included in this study: Without the use of antihypertensive drugs, blood pressure was measured three times on different days, and all met the criteria of SBP=140mmHg and/or DBP=90mmHg. (2) A clear diagnosis of essential hypertension has been made for more than one month; (3) No antihypertensive drugs have been taken or blood pressure has not reached the target after standardized and stable medication for more than one month; If antihypertensive drugs are taken and the medication is standardized for more than one month, and the blood pressure value remains SBP=140mmHg and/or DBP=90mmHg; (4) 30 years old = age =70 years old; (5) Informed consent and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria (1) Those who are known or suspected of having secondary hypertension; (2) Patients with acute cerebral infarction; (3) Pregnant or lactating women and women of childbearing age who have not taken contraceptive measures; (4) Combined with severe liver or kidney function impairment, mental disorders or hematopoietic system diseases; (5) There is an infected person on the skin at or near the acupuncture point; (6) Patients who are currently participating in other clinical trials or those who have participated in other clinical trials within one month. Note: Any patient who meets any of the above conditions should be excluded.

Design outcomes

Primary

MeasureTime frame
24-hour ambulatory blood pressure monitoring;Immediate blood pressure;

Secondary

MeasureTime frame
TCM Symptom Score;Quality of life assessment;

Countries

China

Contacts

Public ContactXifa Xu

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

xuxifa0206@163.com15254168326

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026